hemophilia A	causes	bleeding tendency
hemophilia B	causes	bleeding tendency
von Willebrand disease	causes	mucocutaneous bleeding
disseminated intravascular coagulation	characterized by	thrombosis and bleeding
thrombocytopenia	causes	mucosal bleeding
liver disease	causes	coagulopathy
vitamin K deficiency	causes	prolonged PT
anticoagulant therapy	causes	bleeding risk
warfarin	causes	prolonged INR
heparin	causes	prolonged aPTT
factor VIII deficiency	causes	hemarthrosis
factor IX deficiency	causes	bleeding tendency
factor XI deficiency	causes	prolonged aPTT
disseminated intravascular coagulation	results in	microvascular thrombosis
disseminated intravascular coagulation	results in	hemorrhagic diathesis
fibrinogen deficiency	causes	bleeding
fibrinogen	acts as	coagulation factor
thrombin	converts	fibrinogen
fibrin	forms	clot matrix
fibrinolysis	regulates	clot breakdown
plasminogen	activates	plasmin
plasmin	degrades	fibrin
d-dimer	indicates	fibrinolysis activity
platelets	mediate	primary hemostasis
thrombocytopathy	causes	mucocutaneous bleeding
von Willebrand factor	stabilizes	platelet adhesion
von Willebrand disease	associated with	mucocutaneous bleeding
PT	measures	extrinsic pathway activity
PT	prolonged in	vitamin K deficiency
aPTT	measures	intrinsic pathway activity
aPTT	prolonged in	heparin therapy
INR	reflects	extrinsic pathway function
d-dimer	elevated in	active thrombosis
fibrinogen	consumed in	DIC
prothrombin	deficiency	bleeding tendency
protein C deficiency	causes	thrombosis risk
protein S deficiency	causes	thrombosis risk
antithrombin deficiency	causes	thrombosis risk
antiphospholipid syndrome	causes	thrombosis risk
lupus anticoagulant	associated with	prolonged aPTT
hemostasis	relies on	platelet function
platelet transfusion	used for	thrombocytopenia bleeding
fresh frozen plasma	provides	coagulation factors
cryoprecipitate	provides	fibrinogen
prothrombin complex concentrate	provides	vitamin K dependent factors
recombinant factor VIIa	provides	hemostasis
desmopressin	increases	von Willebrand factor
tranexamic acid	inhibits	fibrinolysis
obstetric hemorrhage	leads to	coagulopathy
placental abruption	causes	obstetric DIC
preeclampsia	associated with	HELLP syndrome
HELLP syndrome	associated with	coagulopathy
vitamin K	reverses	warfarin effect
fresh frozen plasma	used for	clotting factor deficiency
cryoprecipitate	used for	fibrinogen deficiency
fibrinogen concentrate	used for	hypofibrinogenemia
massive transfusion	associated with	coagulopathy
neonatal bleeding	caused by	vitamin K deficiency
hemarthrosis	presents with	joint swelling
intracranial hemorrhage	presents with	neurologic deficit
epistaxis	presents with	mucosal bleeding
gingival bleeding	presents with	mucosal bleeding
bleeding risk	increased by	anticoagulants
bleeding risk	increased by	liver disease
thrombotic risk	increased by	antiphospholipid syndrome
prosthetic valve	requires	anticoagulation
atrial fibrillation	requires	anticoagulation
venous thromboembolism	treated with	anticoagulation
warfarin therapy	monitored by	INR
heparin therapy	monitored by	aPTT
fondaparinux	monitored by	anti-Xa activity
antithrombin deficiency	treated with	plasma infusion
platelet dysfunction	associated with	bleeding tendency
dysfibrinogenemia	causes	abnormal clot formation
thrombotic thrombocytopenic purpura	characterized by	microangiopathic hemolytic anemia
thrombotic microangiopathy	causes	thrombocytopenia
factor V Leiden	causes	thrombosis risk
protein C resistance	associated with	thrombosis risk
heparin-induced thrombocytopenia	causes	thrombosis risk
antifibrinolytic therapy	used for	bleeding control
plasma exchange	used for	thrombotic microangiopathy
factor VIII concentrate	used for	hemophilia A
factor IX concentrate	used for	hemophilia B
plateletpheresis	used for	thrombocytopenia
splenomegaly	associated with	thrombocytopenia
calcium	required for	coagulation cascade
coagulation cascade	includes	intrinsic pathway
coagulation cascade	includes	extrinsic pathway
extrinsic pathway	activated by	tissue factor
tissue factor	activates	factor VII
factor VII	activates	factor X
factor X	converts	prothrombin
prothrombin	converts	thrombin
fibrin	crosslinks	clot stabilization
factor XIII	crosslinks	fibrin
clot stabilization	increases	clot integrity
clot integrity	reduces	bleeding risk
parenteral anticoagulants	require	monitoring
dysregulated hemostasis	associated with	bleeding risk
vasculature fragility	increases	hemorrhage risk
fibrin clot	resistant to	lysis in some conditions
